Persistent hypofibrinolysis in severe COVID-19 associated with elevated fibrinolysis inhibitors activity

Hypercoagulability and reduced fibrinolysis are well-established complications associated with COVID-19. However, the timelines for the onset and resolution of these complications remain unclear. The aim of this study was to evaluate, in a cohort of COVID-19 patients, changes in coagulation and fibr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of thrombosis and thrombolysis 2024-04, Vol.57 (4), p.721-729
Hauptverfasser: Okazaki, Erica, Barion, Bárbara Gomes, da Rocha, Tania Rubia Flores, Di Giacomo, Giovanna, Ho, Yeh-Li, Rothschild, Cynthia, Fatobene, Giancarlo, de Carvalho Moraes, Bruna del Guerra, Stefanello, Bianca, Villaça, Paula Ribeiro, Rocha, Vanderson Geraldo, Orsi, Fernanda Andrade
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!